Pfizer has officially announced the appointment of Amr Seif as the Regional Director for Egypt, Levant, and Iraq, effective September 15. In this pivotal role, Amr will helm the company’s operations across the region and champion various initiatives that bring cutting-edge scientific innovations in vaccines, oncology, rare diseases, internal medicine, hospital care, inflammation, and immunology to the forefront.
Amr’s responsibilities will also encompass the development of strategic initiatives aimed at ensuring equitable access to Pfizer’s latest treatments. This will involve close collaboration with government agencies and regional partners to broaden the reach of advanced medical solutions.
Reflecting on his new appointment, Amr Seif expressed: “I am eager to lead Pfizer’s efforts in Egypt, the Levant, and Iraq. My goal is to sustain and build upon the significant growth and development the company has witnessed in recent years. Collaborating with my esteemed colleagues, I aim to ensure that our latest treatments reach patients and substantially enhance the quality of life for millions. Additionally, I am committed to the continuous transfer of global technology to the region and investing in the development of human resources within the healthcare sector to offer the highest quality services to our patients.”
Amr added, “As I embrace my new responsibilities, I am dedicated to participating in government initiatives aimed at bolstering public health. I will also work closely with both public and private healthcare providers to extend vital health support to the most vulnerable citizens.”
With over 22 years of extensive experience in the pharmaceutical industry, Amr Seif has held various leadership positions, including President of Astellas Middle East and Africa in 2020 and General Manager for the Middle East, North Africa, and Sub-Saharan Africa in 2017. He began his illustrious career in 2004 at MSD Egypt and later advanced to key roles at Hoffmann La Roche Pharmaceuticals in Egypt, culminating in his appointment as the company’s director in the UAE.
Over the years, Pfizer has established a robust presence in Egypt, Levant, and Iraq, significantly contributing to the healthcare landscape in these regions. The company has been pivotal in introducing modern vaccines and treatments, especially in combating infectious diseases and chronic conditions. Pfizer’s efforts have also been instrumental in capacity building within the healthcare sector, including various training initiatives for medical professionals. This long-term commitment has not only improved patient outcomes but has also fostered a collaborative environment with local governments and health organizations, driving forward public health objectives and ensuring a sustainable healthcare infrastructure.
Under Amr Seif’s leadership, Pfizer looks forward to a new era of innovation, growth, and enhanced healthcare delivery in the region.
